Partners in Practice Articles

Inherited Cancer Risk: Determining which patients should consider genetic counseling

Thursday, April 30, 2015 - 11:45am

The past 10 years have led to significant improvements in assessing hereditary cancer risk, due largely to advancements in genetic testing technology, knowledge of hereditary cancer risks and the identification of new cancer-associated genes.

Read more

Cytoreduction/HIPEC in Gastric Cancer: Who benefits, and when to consider it?

Monday, March 23, 2015 - 11:30am
Gastric adenocarcinoma commonly spreads through carcinomatosis or peritoneal metastases (PM). This was often discovered at the time of attempted curative gastric resection, given the poor ability of preoperative staging CT scans to detect the presence and extent of PM. In patients where visible PMs are absent, diagnostic laparoscopy with peritoneal lavage and cytology has been shown to be an effective method of noting free intraperitoneal tumor cells. This is also defined as M1 disease and is generally associated with T3 or T4 primary gastric cancers.
Read more

Evolving Surgical Approaches to Treating Advanced Gastric Cancer

Monday, March 23, 2015 - 10:45am
There has been significant debate over the use of minimally invasive resection for the management of advanced gastric cancer. Laparoscopic surgery appears as a favorable approach, given the previously reported decrease in postoperative pain, pulmonary complications, and hospital lengths of stay. The reluctance to widely adopt this technique centers on concerns about its oncologic completeness and the complexity of the procedure.
Read more

Anti-PD1 Therapy in Melanoma and Lung Cancer

Thursday, April 30, 2015 - 10:30am

by Usha Malhotra, MD, Formerly of Roswell Park 
Assistant Professor of Oncology

Read more

Advances in Treatment of Neuroendocrine Cancers

Wednesday, January 7, 2015 - 2:30pm

by Renuka Iyer, MD

To prepare for the second annual Roswell Park Cancer Institute (RPCI) patient seminar on neuroendocrine cancer on October 18, 2014, I sat down to think about the progress made in this field.

Read more

Selecting the Optimal Liver-Directed Therapy for NETs

Thursday, December 18, 2014 - 3:30pm

by Smit Singla, MD, MRCSEd, MSc, and Boris Kuvshinoff, MD, MBA

Neuroendocrine tumors (NET) are a group of relatively slow-growing tumors that arise mostly in the pulmonary and gastrointestinal system. Considered rare, their incidence has increased 6.3% in the last 25 years, with a prevalence of 35 per 100,000 patients. Because patients with these tumors generally present with vague symptoms, the diagnosis is often delayed by five to seven years.

Read more

Minimally Invasive Posterior Adrenalectomy: New Approach Offers Multiple Benefits

Thursday, December 18, 2014 - 3:15pm

by Steven Hochwald, MD

There are several ways to remove the adrenal gland. For many years the minimally invasive transperitoneal approach has been the preferred technique and is now used more than any other. Yet it has limitations, including painful and unsightly incisions on the anterior abdominal wall.

Read more

Advances in Endocrine Surgery for Hyperparathyroidism: Pre-Surgical Imaging Using 4DCT and Eliminating Intraoperative PTH Monitoring

Thursday, December 18, 2014 - 3:00pm

by Moshim Kukar, MD

Primary hyperparathyroidism is a common disorder in which one or more parathyroid glands are abnormally enlarged. Surgical removal of the enlarged glands is the definitive treatment. The traditional surgical approach of four-gland exploration has been largely replaced with minimally invasive parathyroidectomy (MIP), which reduces the incidence of such associated complications as permanent hypocalcemia and recurrent laryngeal nerve injury.

Read more

OmniSeq Target™ Helps to Integrate Personalized Genomic Medicine in Routine Cancer Care

Friday, November 21, 2014 - 9:30am

OmniSeq Target™ is a multi-analyte test platform developed by the Center for Personalized Medicine at Roswell Park Cancer Institute (RPCI) to determine the presence or absence of relevant tumor genomic alterations that impact therapeutic decisions.

Read more

When Cancer Recurs, Phase I Clinical Trials Can Expand Treatment Options

Thursday, November 20, 2014 - 4:15pm

Most cancer patients with refractory disease have limited choices on the menu of standard treatments, but phase I clinical trials can expand those options and offer hope.

Read more

What Can Interventional Pulmonology Do for Your Patient?

Thursday, November 20, 2014 - 4:00pm

The relatively new and growing field of interventional pulmonology is an area of pulmonary medicine that focuses on using minimally invasive endoscopic techniques to diagnose and treat lung, thoracic, tracheal and mediastinal conditions.

Read more

The Vital Role of Endoscopy At Every Step of Esophageal Cancer Care

Thursday, October 23, 2014 - 2:15pm

by Andrew Bain, MD

Endoscopy plays a paramount role in the diagnosis, staging, treatment, and palliation of esophageal cancer.

Read more